Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA

Por Brod, Meryl, Adler, Lenard A., Lipsius, Sarah, Tanaka, Yoko, Heinloth, Alexandra N., Upadhyaya, Himanshu
Publicado no Atten Defic Hyperact Disord (2015)

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

Por Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Publicado no J Headache Pain (2019)

Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

Por Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Publicado no J Headache Pain (2019)

Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder

Por Upadhyaya, Himanshu, Kratochvil, Christopher, Ghuman, Jaswinder, Camporeale, Angelo, Lipsius, Sarah, D'Souza, Deborah, Tanaka, Yoko
Publicado no J Child Adolesc Psychopharmacol (2015)

Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain

Por Skljarevski, Vladimir, Frakes, Elijah P., Sagman, Doron, Lipsius, Sarah, Heinloth, Alexandra N., Dueñas Tentori, Héctor J.
Publicado em 2012

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Plac...

Por Smitherman, Todd A., Tietjen, Gretchen E., Schuh, Kory, Skljarevski, Vladimir, Lipsius, Sarah, D’Souza, Deborah N., Pearlman, Eric M.
Publicado no Headache (2020)